Clinical trial
A Pilot Study to Assess the Safety and Feasibility of Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.
NCT05498051 is registered in ClinicalTrials.gov with Meander Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Assess the Safety and Feasibility of Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.
- Lead sponsor
- Meander Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2022
- Completion date
- June 1, 2023
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colonic neoplasms, colorectal neoplasms, fluorescence, sentinel lymph node